Compare NTES & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NTES | GSK |
|---|---|---|
| Founded | 1997 | 1715 |
| Country | China | United Kingdom |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 84.7B | 93.3B |
| IPO Year | 2002 | 2013 |
| Metric | NTES | GSK |
|---|---|---|
| Price | $125.74 | $49.60 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 33 | 9 |
| Target Price | ★ $162.81 | $60.51 |
| AVG Volume (30 Days) | 500.1K | ★ 4.6M |
| Earning Date | 11-19-2026 | 10-28-2026 |
| Dividend Yield | 2.30% | ★ 3.64% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $7.20 | $3.81 |
| Revenue Next Year | $7.61 | $4.74 |
| P/E Ratio | $79.88 | ★ $32.75 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $106.06 | $42.85 |
| 52 Week High | $153.54 | $61.70 |
| Indicator | NTES | GSK |
|---|---|---|
| Relative Strength Index (RSI) | 58.93 | 56.61 |
| Support Level | $118.96 | $48.23 |
| Resistance Level | $127.98 | $51.65 |
| Average True Range (ATR) | 1.65 | 0.80 |
| MACD | 0.90 | 0.28 |
| Stochastic Oscillator | 86.84 | 90.70 |
Founded in the late 1990s as an internet portal, NetEase has evolved into China's second-largest online gaming company. Its early success was anchored by the massively multiplayer online role-playing game Fantasy Westward Journey, which laid the foundation for a durable franchise strategy. Over the past decade, the company has expanded its portfolio with successful titles such as Justice, Identity V, Naraka: Bladepoint, and Eggy Party, all of which continue to maintain sizable and engaged player bases.In addition to its in-house development capabilities, NetEase partners with global IP holders such as Microsoft and Marvel to develop and publish titles based on established franchises, including World of Warcraft, Diablo Immortal, and Marvel Rivals, further strengthening its global presence.
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.